SALARIUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.478 USD | +3.20% |
|
-1.20% | -26.46% |
| 05-13 | Salarius Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-25 | Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +3.20% | -1.20% | -26.46% | -70.31% | - | 2.28M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SLRX Stock
- Charts Salarius Pharmaceuticals, Inc.
- Comparison Chart
